Theodore R. Schroeder

Insider Reports History

Location
San Diego, CA
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Theodore R. Schroeder:

Company Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. Director Common Stock 21,000 $95,577 $4.55 16 Apr 2025 Direct
Nabriva Therapeutics plc Director Ordinary Shares 11,989 $17,984 $1.50 29 Jan 2023 Direct
Phathom Pharmaceuticals, Inc. Director Common Stock (Right to Buy) 35,000 16 Apr 2025 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27,500 21 Jun 2022 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 0 07 Jan 2026 Direct
Phathom Pharmaceuticals, Inc. Director No securities are beneficially owned. 0 16 Apr 2025 Direct

Insider Reports Filed by Theodore R. Schroeder

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CDTX Cidara Therapeutics, Inc. 07 Jan 2026 11 $0 4 Director 07 Jan 2026, 20:17
CDTX Cidara Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 18 Jun 2025, 17:05
PHAT Phathom Pharmaceuticals, Inc. 16 Apr 2025 2 $0 4 Director 16 Apr 2025, 17:44
PHAT Phathom Pharmaceuticals, Inc. 16 Apr 2025 0 $0 3 Director 16 Apr 2025, 17:37
CDTX Cidara Therapeutics, Inc. 17 Dec 2024 1 $0 4 Director 19 Dec 2024, 18:19
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 1 $0 4 Director 19 Jul 2024, 16:49
CDTX Cidara Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:23
/report/000110465923008854-schroeder-theodore-r-2023-01-29 Nabriva Therapeutics plc 29 Jan 2023 1 -$646 4 Director 31 Jan 2023, 19:55
/report/000110465923002821-schroeder-theodore-r-2023-01-06 Nabriva Therapeutics plc 06 Jan 2023 1 -$14.3 4 Chief Executive Officer, Director 10 Jan 2023, 16:56
/report/000110465923001008-schroeder-theodore-r-2022-12-31 Nabriva Therapeutics plc 31 Dec 2022 1 -$9.45 4 Chief Executive Officer, Director 04 Jan 2023, 17:09
/report/000110465922125506-schroeder-theodore-r-2022-12-06 Nabriva Therapeutics plc 06 Dec 2022 1 -$18.18 4 Chief Executive Officer, Director 08 Dec 2022, 15:34
/report/000110465922124180-schroeder-theodore-r-2022-11-30 Nabriva Therapeutics plc 30 Nov 2022 1 -$11.25 4 Chief Executive Officer, Director 02 Dec 2022, 16:15
/report/000110465922116022-schroeder-theodore-r-2022-11-06 Nabriva Therapeutics plc 06 Nov 2022 1 -$22.39 4 Chief Executive Officer, Director 08 Nov 2022, 16:24
/report/000110465922113574-schroeder-theodore-r-2022-10-31 Nabriva Therapeutics plc 31 Oct 2022 1 -$12.7 4 Chief Executive Officer, Director 01 Nov 2022, 17:08
/report/000110465922107772-schroeder-theodore-r-2022-10-06 Nabriva Therapeutics plc 06 Oct 2022 1 -$24.48 4 Chief Executive Officer, Director 11 Oct 2022, 17:03
/report/000110465922106053-schroeder-theodore-r-2022-09-30 Nabriva Therapeutics plc 30 Sep 2022 1 -$10.4 4 Chief Executive Officer, Director 04 Oct 2022, 21:31
/report/000110465922098289-schroeder-theodore-r-2022-09-06 Nabriva Therapeutics plc 06 Sep 2022 1 -$35.24 4 Chief Executive Officer, Director 07 Sep 2022, 18:00
/report/000110465922097114-schroeder-theodore-r-2022-08-31 Nabriva Therapeutics plc 31 Aug 2022 1 -$17.61 4 Chief Executive Officer, Director 01 Sep 2022, 18:38
/report/000110465922091492-schroeder-theodore-r-2022-08-11 Nabriva Therapeutics plc 11 Aug 2022 4 $0 4 Chief Executive Officer, Director 15 Aug 2022, 20:50
/report/000110465922087403-schroeder-theodore-r-2022-08-06 Nabriva Therapeutics plc 06 Aug 2022 1 -$41.56 4 Chief Executive Officer, Director 08 Aug 2022, 17:44
/report/000110465922085786-schroeder-theodore-r-2022-07-31 Nabriva Therapeutics plc 31 Jul 2022 1 -$19.15 4 Chief Executive Officer, Director 03 Aug 2022, 21:45
/report/000110465922078028-schroeder-theodore-r-2022-07-06 Nabriva Therapeutics plc 06 Jul 2022 1 -$41 4 Chief Executive Officer, Director 07 Jul 2022, 16:11
/report/000110465922076941-schroeder-theodore-r-2022-06-30 Nabriva Therapeutics plc 30 Jun 2022 1 -$19.47 4 Chief Executive Officer, Director 01 Jul 2022, 18:08
CDTX Cidara Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 17:25
/report/000120919122038892-schroeder-theodore-r-2022-06-21 OTONOMY, INC. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:35
/report/000110465922068985-schroeder-theodore-r-2022-06-06 Nabriva Therapeutics plc 06 Jun 2022 1 -$45 4 Chief Executive Officer, Director 07 Jun 2022, 16:47
/report/000110465922067620-schroeder-theodore-r-2022-05-31 Nabriva Therapeutics plc 31 May 2022 1 -$22.11 4 Chief Executive Officer, Director 02 Jun 2022, 16:10
/report/000110465922057688-schroeder-theodore-r-2022-05-06 Nabriva Therapeutics plc 06 May 2022 1 -$58.5 4 Chief Executive Officer, Director 09 May 2022, 18:32
/report/000110465922055332-schroeder-theodore-r-2022-04-30 Nabriva Therapeutics plc 30 Apr 2022 1 -$33.17 4 Chief Executive Officer, Director 03 May 2022, 16:59
/report/000110465922044220-schroeder-theodore-r-2022-04-06 Nabriva Therapeutics plc 06 Apr 2022 1 -$89.79 4 Chief Executive Officer, Director 08 Apr 2022, 16:16
/report/000110465922042376-schroeder-theodore-r-2022-03-31 Nabriva Therapeutics plc 31 Mar 2022 1 -$43.68 4 Chief Executive Officer, Director 04 Apr 2022, 18:27
/report/000110465922031514-schroeder-theodore-r-2022-03-06 Nabriva Therapeutics plc 06 Mar 2022 1 -$113 4 Chief Executive Officer, Director 08 Mar 2022, 15:12
/report/000110465922029492-schroeder-theodore-r-2022-02-28 Nabriva Therapeutics plc 28 Feb 2022 1 -$56.25 4 Chief Executive Officer, Director 02 Mar 2022, 18:51
/report/000110465922013893-schroeder-theodore-r-2022-02-06 Nabriva Therapeutics plc 06 Feb 2022 1 -$126 4 Chief Executive Officer, Director 08 Feb 2022, 15:25
/report/000110465922010535-schroeder-theodore-r-2022-01-29 Nabriva Therapeutics plc 29 Jan 2022 2 -$4,905 4 Chief Executive Officer, Director 01 Feb 2022, 19:47
/report/000110465922010487-schroeder-theodore-r-2022-01-28 Nabriva Therapeutics plc 28 Jan 2022 2 $0 4 Chief Executive Officer, Director 01 Feb 2022, 17:37
/report/000110465922002736-schroeder-theodore-r-2022-01-06 Nabriva Therapeutics plc 06 Jan 2022 1 -$157 4 Chief Executive Officer, Director 10 Jan 2022, 15:19
/report/000110465922000973-schroeder-theodore-r-2021-12-31 Nabriva Therapeutics plc 31 Dec 2021 1 -$64.2 4 Chief Executive Officer, Director 04 Jan 2022, 16:06
/report/000110465921154397-schroeder-theodore-r-2021-12-28 Nabriva Therapeutics plc 28 Dec 2021 1 +$57,320 4 Chief Executive Officer, Director 29 Dec 2021, 20:32
/report/000110465921147690-schroeder-theodore-r-2021-12-06 Nabriva Therapeutics plc 06 Dec 2021 1 -$162 4 Chief Executive Officer, Director 08 Dec 2021, 16:14
/report/000110465921145998-schroeder-theodore-r-2021-11-30 Nabriva Therapeutics plc 30 Nov 2021 1 -$83.46 4 Chief Executive Officer, Director 02 Dec 2021, 17:31
/report/000110465921136404-schroeder-theodore-r-2021-11-06 Nabriva Therapeutics plc 06 Nov 2021 1 -$299 4 Chief Executive Officer, Director 09 Nov 2021, 16:38
/report/000110465921132492-schroeder-theodore-r-2021-10-31 Nabriva Therapeutics plc 31 Oct 2021 1 -$123 4 Chief Executive Officer, Director 01 Nov 2021, 19:51
/report/000110465921124665-schroeder-theodore-r-2021-10-06 Nabriva Therapeutics plc 06 Oct 2021 1 -$243 4 Chief Executive Officer, Director 08 Oct 2021, 16:39
/report/000110465921122510-schroeder-theodore-r-2021-09-30 Nabriva Therapeutics plc 30 Sep 2021 1 -$127 4 Chief Executive Officer, Director 04 Oct 2021, 16:14
/report/000110465921116048-schroeder-theodore-r-2021-09-14 Nabriva Therapeutics plc 14 Sep 2021 1 +$56,500 4 Chief Executive Officer, Director 15 Sep 2021, 20:00
/report/000110465921113876-schroeder-theodore-r-2021-09-06 Nabriva Therapeutics plc 06 Sep 2021 1 -$250 4 Chief Executive Officer, Director 08 Sep 2021, 17:27
/report/000110465921112479-schroeder-theodore-r-2021-08-31 Nabriva Therapeutics plc 31 Aug 2021 1 -$113 4 Chief Executive Officer, Director 02 Sep 2021, 16:07
/report/000110465921102956-schroeder-theodore-r-2021-08-06 Nabriva Therapeutics plc 06 Aug 2021 1 -$263 4 Chief Executive Officer, Director 10 Aug 2021, 17:16
/report/000110465921099448-schroeder-theodore-r-2021-07-31 Nabriva Therapeutics plc 31 Jul 2021 1 -$118 4 Chief Executive Officer, Director 03 Aug 2021, 16:09
/report/000110465921090218-schroeder-theodore-r-2021-07-06 Nabriva Therapeutics plc 06 Jul 2021 1 -$286 4 Chief Executive Officer, Director 08 Jul 2021, 16:11
/report/000110465921088851-schroeder-theodore-r-2021-06-30 Nabriva Therapeutics plc 30 Jun 2021 1 -$144 4 Chief Executive Officer, Director 02 Jul 2021, 16:06
CDTX Cidara Therapeutics, Inc. 23 Jun 2021 1 $0 4 Director 24 Jun 2021, 18:01
/report/000120919121043076-schroeder-theodore-r-2021-06-22 OTONOMY, INC. 22 Jun 2021 1 $0 4 Director 24 Jun 2021, 17:04
/report/000110465921078230-schroeder-theodore-r-2021-06-06 Nabriva Therapeutics plc 06 Jun 2021 1 -$302 4 Chief Executive Officer, Director 08 Jun 2021, 16:10
/report/000110465921075737-schroeder-theodore-r-2021-05-31 Nabriva Therapeutics plc 31 May 2021 1 -$148 4 Chief Executive Officer, Director 02 Jun 2021, 16:12
/report/000110465921064055-schroeder-theodore-r-2021-05-06 Nabriva Therapeutics plc 06 May 2021 1 -$335 4 Chief Executive Officer, Director 10 May 2021, 17:53